📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Biomage

1.1 - Company Overview

Biomage Logo

Biomage

Headquarter: United Kingdom
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of single-cell RNA-seq data analysis and visualization tools and services, including Cellenics® for no-code analysis, a comprehensive course on mastering single-cell RNA-seq with Cellenics®, and private, secure Cellenics® deployment with integration, technical support, and feature development.

Products and services

  • Cellenics®: An open-source data analysis and visualization product for single-cell RNA sequencing data, enabling biologists to analyze datasets without coding skills through intuitive exploration of results
  • Private Cellenics® Deployment & Support: A secure private deployment on client infrastructure delivering integration, technical support, and feature development for Cellenics®
  • Mastering Single Cell RNA-seq Data Analysis with Cellenics®: An instructor-guided comprehensive course teaching single-cell RNA-seq analysis using Cellenics®, with video lessons, PDF materials, and personalized sessions for practical proficiency

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Biomage

Adimab Logo

Adimab

HQ: United States Website
  • Description: Provider of an antibody discovery and optimization platform developing full-length human Immunoglobulin Gs.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Adimab company profile →
Cyrus Logo

Cyrus

HQ: United States Website
  • Description: Provider of protein design software and services, including the Rosetta software combining physics-based modeling and statistical patterns to design protein binders, de novo proteins, and assemblies; the Cyrus software platform with Rosetta protocols, AI, cloud workflow automation, and in-house structure/data analysis; services for protein design, deep mutational scanning, cytokine engineering; and Next Gen IdeS enzyme for IgG-mediated disorders.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cyrus company profile →
Enterome Logo

Enterome

HQ: France Website
  • Description: Provider of clinical-stage immunomodulatory drugs for cancer and immune diseases, offering OncoMimics, a cancer immunotherapy using bacterial peptides to mimic tumor antigens, with Phase 2 candidates EO2401 (glioblastoma/adrenal), EO2463 (indolent NHL) and EO4010 (third-line colorectal), and EndoMimics oral bioactives for inflammatory/autoimmune diseases, including EB1010 for food allergies and IBD.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Enterome company profile →
Synthesis Med Chem Logo

Synthesis Med Chem

HQ: United States Website
  • Description: Provider of small molecule drug discovery services, offering integrated drug discovery from hit identification to preclinical candidate nomination; medicinal and synthetic chemistry; custom synthesis; targeted protein degradation (PROTACs & molecular glues); antibody-drug conjugate development; and hit discovery supported by protein production and structural biology services from Viva Biotech.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Synthesis Med Chem company profile →
MedAvante-ProPhase Logo

MedAvante-ProPhase

HQ: United States Website
  • Description: Provider of technology-enabled signal detection solutions in clinical trials of treatments for nervous system disorders.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full MedAvante-ProPhase company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Biomage

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Biomage

2.2 - Growth funds investing in similar companies to Biomage

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Biomage

4.2 - Public trading comparable groups for Biomage

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Biomage

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Biomage

What does Biomage do?

Biomage is a provider of single-cell RNA-seq data analysis and visualization tools and services, including Cellenics® for no-code analysis, a comprehensive course on mastering single-cell RNA-seq with Cellenics®, and private, secure Cellenics® deployment with integration, technical support, and feature development.

Who are Biomage's competitors?

Biomage's competitors and similar companies include Adimab, Cyrus, Enterome, Synthesis Med Chem, and MedAvante-ProPhase.

Where is Biomage headquartered?

Biomage is headquartered in United Kingdom.

How many employees does Biomage have?

Biomage has 1,000 employees 🔒.

When was Biomage founded?

Biomage was founded in 2010 🔒.

What sector and industry vertical is Biomage in?

Biomage is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Biomage

Who are the top strategic acquirers in Biomage's sector and industry

Top strategic M&A buyers and acquirers in Biomage's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Biomage?

Top strategic M&A buyers groups and sectors for Biomage include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Biomage's sector and industry vertical

Which are the top PE firms investing in Biomage's sector and industry vertical?

Top PE firms investing in Biomage's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Biomage's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Biomage's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Biomage's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Biomage include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Biomage's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Biomage?

The key public trading comparables and valuation benchmarks for Biomage include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Biomage for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Biomage with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Biomage's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Biomage with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Biomage's' sector and industry vertical?

Access recent funding rounds and capital raises in Biomage's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Biomage